ASBPW vs IIPR

Innovative Industrial Properties, Inc.

(IIPR) offers the better valuation at 14. 4x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Innovative Industrial Properties, Inc. (IIPR) a "Hold" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Innovative Industrial Properties, Inc.

(IIPR) delivered a total return of -50. 0%, compared to -81. 9% for Aspire Biopharma Holdings, Inc. (ASBPW). Over 10 years, the gap is even starker: IIPR returned +436. 4% versus ASBPW's -81. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Innovative Industrial Properties, Inc.

(IIPR) is the lower-risk stock at 0. 92β versus Aspire Biopharma Holdings, Inc. 's 3. 15β — meaning ASBPW is approximately 244% more volatile than IIPR relative to the S&P 500.

On earnings-per-share growth, the picture is similar: Innovative Industrial Properties, Inc.

grew EPS -28. 8% year-over-year, compared to -381. 5% for Aspire Biopharma Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Innovative Industrial Properties, Inc.

(IIPR) is the more profitable company, earning 43. 0% net margin versus -16351. 8% for Aspire Biopharma Holdings, Inc. — meaning it keeps 43. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IIPR leads at 46. 7% versus -10314. 0% for ASBPW. At the gross margin level — before operating expenses — IIPR leads at 88. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, IIPR (13.

5% yield) pays a dividend. ASBPW does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Innovative Industrial Properties, Inc.

(IIPR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 92), 13. 5% yield, +436. 4% 10Y return). Aspire Biopharma Holdings, Inc. (ASBPW) carries a higher beta of 3. 15 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IIPR: +436. 4%, ASBPW: -81. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (ASBPW (Healthcare) and IIPR (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: ASBPW is a small-cap quality compounder stock; IIPR is a small-cap deep-value stock. IIPR pays a dividend while ASBPW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.